Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6174)
All Articles published online
|
Jan 14, 2011 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Liu J, Fu XQ, Zhou W, Yu HG, Yu JP, Luo HS. LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i2/181.htm |
| Number | Citing Articles |
| 1 |
Jennifer W. Harris, Tianyan Gao, B. Mark Evers. Intestinal Tumorigenesis. 2015; : 101 doi: 10.1007/978-3-319-19986-3_4
|
| 2 |
Qianhui Sun, Jingyuan Wu, Guanghui Zhu, Tingting Li, Xiaoyu Zhu, Baoyi Ni, Bowen Xu, Xinyi Ma, Jie Li. Lactate-related metabolic reprogramming and immune regulation in colorectal cancer. Frontiers in Endocrinology 2023; 13 doi: 10.3389/fendo.2022.1089918
|
| 3 |
Ahmad R. Safa, Karen E. Pollok. Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy. Cancers 2011; 3(2): 1639 doi: 10.3390/cancers3021639
|
| 4 |
Zhen Lu, Aman Xu, Xiao Yuan, Kaiwei Chen, Likun Wang, Tao Guo. Anticancer effect of resibufogenin on gastric carcinoma cells through the phosphoinositide 3‑kinase/protein kinase�B/glycogen synthase kinase 3β signaling pathway. Oncology Letters 2018; doi: 10.3892/ol.2018.8979
|
| 5 |
CHENFEI ZHOU, JUN JI, MIN SHI, LIU YANG, YINGYAN YU, BINGYA LIU, ZHENGGANG ZHU, JUN ZHANG. Suberoylanilide hydroxamic acid enhances the antitumor activity of oxaliplatin by reversing the oxaliplatin-induced Src activation in gastric cancer cells. Molecular Medicine Reports 2014; 10(5): 2729 doi: 10.3892/mmr.2014.2548
|
| 6 |
Leimarembi Devi Naorem, Mathavan Muthaiyan, Ishita Bhattacharyya, Dinakara Rao Ampasala, Amouda Venkatesan. A Theranostic and Precision Medicine Approach for Female-Specific Cancers. 2021; : 31 doi: 10.1016/B978-0-12-822009-2.00002-9
|
| 7 |
Olga Kersy, Shelly Loewenstein, Nir Lubezky, Osnat Sher, Natalie B. Simon, Joseph M. Klausner, Guy Lahat. Omental Tissue-Mediated Tumorigenesis of Gastric Cancer Peritoneal Metastases. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01267
|
| 8 |
Guoqiong Lei, Sushun Liu, Xin Yang, Chao He, Ravindran Caspa Gokulan. TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/8870907
|
| 9 |
Giuseppe Siragusa, Laura Tomasello, Carla Giordano, Giuseppe Pizzolanti. Survivin (BIRC5): Implications in cancer therapy. Life Sciences 2024; 350: 122788 doi: 10.1016/j.lfs.2024.122788
|
| 10 |
Duncan Ayers, Alessandro Nasti. Utilisation of Nanoparticle Technology in Cancer Chemoresistance. Journal of Drug Delivery 2012; 2012: 1 doi: 10.1155/2012/265691
|
| 11 |
Guiqin Hou, Qi Zhao, Mengying Zhang, Tianli Fan, Mingyue Liu, Xiaojing Shi, Yandan Ren, Yang Wang, Jiaxu Zhou, Zhaoming Lu. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy 2018; 106: 1348 doi: 10.1016/j.biopha.2018.07.075
|
| 12 |
Hui Zhang, Yidan Lin, Minxue Zhuang, Lin Zhu, Yongmei Dai, Mengbo Lin. Screening and identification of CNIH4 gene associated with cell proliferation in gastric cancer based on a large-scale CRISPR-Cas9 screening database DepMap. Gene 2023; 850: 146961 doi: 10.1016/j.gene.2022.146961
|
| 13 |
Feng Qiu, Chun‐hua Shi, Jun Zheng, Yu‐bin Liu. Periostin Mediates the Increased Pro‐Angiogenic Activity of Gastric Cancer Cells under Hypoxic Conditions. Journal of Biochemical and Molecular Toxicology 2013; 27(7): 364 doi: 10.1002/jbt.21498
|
| 14 |
R. Reilly, M. S. Mroz, E. Dempsey, K. Wynne, S. J. Keely, E. F. McKone, C. Hiebel, C. Behl, J. A. Coppinger. Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06588-z
|
| 15 |
Yue Song, Zhao-xia Li, Xi Liu, Rui Wang, Li-wei Li, Qingyu Zhang. The Wnt/β-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation. Tumor Biology 2017; 39(7): 101042831771261 doi: 10.1177/1010428317712617
|
| 16 |
Yi-Jun Wang, Xiao-Li Xie, Hong-Qun Liu, Hui Tian, Xiao-Yu Jiang, Jiu-Na Zhang, Sheng-Xiong Chen, Ting Liu, Shu-Ling Wang, Xue Zhou, Xiao-Xu Jin, Shi-Mao Liu, Hui-Qing Jiang. Prostaglandin F<sub>2α</sub> synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F<sub>2α</sub>-dependent and F<sub>2α</sub>-independent mechanism. World Journal of Gastroenterology 2023; 29(39): 5452-5470 doi: 10.3748/wjg.v29.i39.5452
Abstract(570) |
Core Tip(562) |
Full Article(HTML)(2071)
|
Full Article with Cover (PDF)-30122K(108)
|
Full Article (Word)-8578K(30)
|
Audio-9262K(9)
|
Peer-Review Report-234K(60)
|
Answering Reviewers-832K(66)
|
Supplementary Material-830K(72)
|
Full Article (PDF)-29404K(136)
|
Full Article (XML)-147K(60)
|
Times Cited (4)
|
Total Visits (6123)
|
Open
|